Technology Labs ResolX reaches 14 enterprise deployments

One Point One Technology Labs Pvt. Ltd. reported 14 ResolX deployments across seven large enterprise clients in the quarter ended 30 September 2026, up by two from 12 previously reported for Q1 FY27. The subsidiary also disclosed four product developments, including live life-insurance applications and an internal hiring deployment.

How many ResolX deployments has Technology Labs reached?

Technology Labs has reached 14 deployments of its ResolX agentic artificial intelligence platform across seven large enterprise clients. One Point One Solutions Limited disclosed the total in its 4 November 2026 earnings release covering the quarter ended 30 September 2026, and said it compared with 12 deployments previously reported for Q1 FY27.

The change represents two additional deployments between the Q1 FY27 and Q2 FY27 company updates. The release does not identify the full client base, specify implementation dates, or assign revenue and contract values to individual ResolX deployments.

Technology Labs develops and commercialises proprietary artificial intelligence technology separately from One Point One Solutions Limited’s customer-experience and enterprise-operations business. ResolX is its flagship platform, designed around Resolution-as-a-Service, or RaaS, which the company says orchestrates workflows for end-to-end resolution of customer and business processes.

The 14-deployment count exceeds the seven-client count, meaning more than one deployment is present across at least some clients. The company describes those customers as large enterprises, while providing detailed industry context only for several of the named product developments.

Which ResolX products has Technology Labs disclosed?

Technology Labs disclosed four ResolX product developments: Omvia, Frequensee, NETS and RightFIT. Omvia is live with a life-insurance client and includes agentic-bot capabilities in seven Indian languages, according to the Q2 FY27 release.

Frequensee is live in a life-insurance environment. NETS received deployment approval for a life-insurance sales use case within its first month of release, a different stage from the live status stated for Omvia and Frequensee.

RightFIT has been deployed internally within One Point One Solutions Limited to support senior-leadership hiring. This is the only named development explicitly described as an internal application, rather than a client-facing insurance or customer-experience use case.

The disclosed updates show products at different commercial and operational stages: two live insurance applications, one approved for deployment, and one already used for internal recruitment. Technology Labs does not disclose the number of deployments associated with each product, the number of users, or whether individual products are used by more than one enterprise client.

How is Technology Labs commercialising ResolX?

Technology Labs is pursuing ResolX commercialisation through usage-based and outcome-linked models. The company says the platform combines agentic artificial intelligence, intelligent orchestration, enterprise workflows, governed data and human expertise across voice, chat, email and digital channels.

Under its RaaS model, ResolX is designed to act, orchestrate and resolve processes rather than simply answer queries, according to the release. The stated focus is complex, domain-intensive and regulated workflows where artificial intelligence works alongside human judgement and enterprise accountability.

One Point One Solutions Limited’s enterprise relationships, domain expertise and global delivery infrastructure may support ResolX adoption, the company said. However, the release distinguishes the businesses by stating that platform ownership and development remain with Technology Labs.

The company does not disclose ResolX pricing, usage volumes, outcome measures, recurring revenue, margins or the proportion of contracts using each commercial model. The 14-deployment figure therefore evidences reported adoption progress, but the filing does not quantify Technology Labs’ contribution to Q2 FY27 revenue or profit.

What was the financial backdrop to ResolX expansion?

One Point One Solutions Limited reported consolidated revenue from operations of Rs 174.96 crore in Q2 FY27, up 147% year on year from Rs 70.87 crore and up 10.5% sequentially from Rs 158.32 crore in Q1 FY27. Earnings before interest, tax, depreciation and amortisation, or EBITDA, were Rs 45.32 crore in Q2 FY27, compared with Rs 21.72 crore a year earlier.

The company’s EBITDA margin was 25.9% in Q2 FY27, against 30.6% in Q2 FY26 and 24.9% in Q1 FY27. That was a 475-basis-point year-on-year decline but a 103-basis-point sequential increase; one basis point equals one-hundredth of a percentage point.

For H1 FY27, One Point One Solutions Limited reported revenue of Rs 333.28 crore, EBITDA of Rs 84.69 crore and profit after tax of Rs 34.72 crore. The release says final figures, growth rates and margin movements are to be reconciled with board-approved results, while the Q1 FY27 comparator values are taken from a working draft and require confirmation.

Management said it is increasing the use of artificial-intelligence-led tools in customer-experience delivery to improve productivity and resolution efficiency. Separately, it said Technology Labs is expanding ResolX adoption, while multi-year contracts include a four-year Costa Rica engagement worth USD 10.8 million and a Rs 39.32 crore power-utility mandate.

Conclusion

Technology Labs’ ResolX deployment total rose from 12 in the Q1 FY27 update to 14 across seven large enterprise clients in the Q2 FY27 disclosure. Its named product activity spans seven-language life-insurance bots through Omvia, a live insurance environment for Frequensee, deployment approval for NETS within one month of release, and an internal leadership-hiring use case for RightFIT.

The next disclosures to watch are management’s stated plans to expand artificial-intelligence adoption, convert its pipeline into long-term engagements and sustain renewals with improved margins. Revenue, pricing, customer-level deployment details and the financial contribution of the usage-based and outcome-linked ResolX models remain undisclosed in the 4 November 2026 release.